Prevention of Transplantation-Associated Arteriosclerosis by Antiadhesion Therapy

  • Mitsuaki Isobe
  • Jun-Ichi Suzuki
Part of the Progress in Experimental Cardiology book series (PREC, volume 1)


Although it seems highly likely that an immunological response against the transplanted coronary endothelium is an important facet of the etiology of graft coronary arteriopathy, important questions regarding the molecular targets and the relative role of the cellular and humoral response remain unanswered. Graft coronary arteriopathy also serves as a model for the study of other forms of coronary arterial disease. Extensive research into this condition will help provide insight into aspects of this disease, as well as those of ordinary coronary atherosclerosis and restenosis after coronary angioplasty.


Cardiac Allograft Intimal Thickening Heart Lung Transplant Cell Cycle Regulatory Gene Smooth Muscle Myosin Heavy Chain 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hosenpud JD, Novick RJ, Bennett LE, Keck BM, Fiol B, Daily OP. 1996. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report-1996. J Heart Lung Transplant 15:655–674.PubMedGoogle Scholar
  2. 2.
    Uretsky BF, Murali S, Reddy PS, Rabin B, Lee A, Griffith BP, Hardesty RL, Trento A, Bahnson HT. 1987. Development of coronary artery disease in cardiac transplant patients receiving immuno-suppressive therapy with cyclosporine and prednisone. Circulation 76:827–834.PubMedGoogle Scholar
  3. 3.
    Johnson DE, Alderman EL, Schroeder JS, Gao SZ, Hunt S, DeCampli WM, Stinson E, Billingham M. 1991. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol 17:449–457.PubMedGoogle Scholar
  4. 4.
    Botas J, Pinto FJ, Chenzbraun A, Liang D, Schroeder JS, Oesterle SN, Alderman EL, Popp RL, Yeung AC. 1995. Influence of preexistent donor coronary artery disease on the progression of transplant vasculopathy. An intravascular ultrasound study. Circulation 92:1126–1132.PubMedGoogle Scholar
  5. 5.
    Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Silverman JF, Wiederhold V, Stinson EB. 1987. Clinical and laboratory correlates of accelerated coronary artery disease in the cardiac transplant patient. Circulation 75:V56–V61.Google Scholar
  6. 6.
    Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. 1988. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 12:334–340.PubMedGoogle Scholar
  7. 7.
    Billingham ME. 1989. Graft coronary disease: the lesions and the patients. Transplant Proc 21:3665–3666.PubMedGoogle Scholar
  8. 8.
    Billingham ME. 1990. Cardiac transplantation. In Sale GE (ed), The Pathology of Organ Transplantation. Boston, MA: Butterworth, pp. 133–152.Google Scholar
  9. 9.
    Hosenpud JD. 1993. Immune mechanism of cardiac allograft vasculopathy: an update. Transplant Immunol 1:231–241.CrossRefGoogle Scholar
  10. 10.
    Suzuki J, Isobe M, Aikawa M, Kawauchi M, Shiojima I, Kobayashi N, Tojo A, Kimura K, Nishikawa T, Sakai T, Sekiguch M, Yazaki Y, Nagai R. 1996. Nonmuscle and smooth muscle myosin heavy chain expression in rejected cardiac allografts—a study in rat and monkey models. Circulation 94:1118–1124.PubMedGoogle Scholar
  11. 11.
    Nagai R, Kuro-o M, Babij P, Periasamy M. 1989. Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J Biol Chem 264:9734–9737.PubMedGoogle Scholar
  12. 12.
    Kuro-o M, Nagai R, Tsuchimochi H, Katoh H, Yazaki Y, Ohkubo A, Takaku F. 1989. Develop-mentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J Biol Chem 264:18272–18275.PubMedGoogle Scholar
  13. 13.
    Aikawa M, Sivam PN, Kuro-o M, Kimura K, Nakahara K, Takewaki S, Ueda M, Yamaguchi H, Yazaki Y, Periasamy M, et al. 1993. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 73:1000–1012.PubMedGoogle Scholar
  14. 14.
    Ross R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801–809.PubMedCrossRefGoogle Scholar
  15. 15.
    Munro JM, Cotran RS. 1988. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 58:249–261.PubMedGoogle Scholar
  16. 16.
    Cybulsky MI, Gimbrone MA Jr. 1991. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788–791.PubMedCrossRefGoogle Scholar
  17. 17.
    van derWal AC, Das PK, Tigges AJ, Becker AE. 1992. Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol 141:1427–1433.PubMedGoogle Scholar
  18. 18.
    Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR. 1992. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 140:665–673.PubMedGoogle Scholar
  19. 19.
    O’Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin CD, et al. 1993. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 92:945–951.PubMedGoogle Scholar
  20. 20.
    Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A. 1993. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 171:223–229.PubMedCrossRefGoogle Scholar
  21. 21.
    Gurtner GC, Davis V, Li H, McCoy MJ, Sharpe A, Cybulsky MI. 1995. Targeted disruption of the murine VCAM-1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Gene Dev 9:1–14.PubMedCrossRefGoogle Scholar
  22. 22.
    O’Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. 1996. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-l in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93:672–682.PubMedGoogle Scholar
  23. 23.
    Isobe M, Yagita H, Okumura K, Ihara A. 1992. Specific acceptance of cardiac allograft after treatment with anti-ICM-1 and anti-LFA-l. Science 255:1125–1127.PubMedCrossRefGoogle Scholar
  24. 24.
    Isobe M, Ihara A. 1993. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation. Transplant Proc 25:1079–1080.PubMedGoogle Scholar
  25. 25.
    Russell PS, Chase CM, Winn HJ, Colvin RB. 1994. Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am J Pathol 144:260–274.PubMedGoogle Scholar
  26. 26.
    Suzuki J, Isobe M, Yamazaki S, Horie S, Okubo Y, Sekiguchi M. 1997. Short-term blockade of ICAM-1 and LFA-1 prevents cardiac allograft arteriopathy in mice. J Heart Lung Transplant 10:1141–1148.Google Scholar
  27. 27.
    Ono K, Lindsey ES. 1969. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 57:225–229.PubMedGoogle Scholar
  28. 28.
    Isobe M, Haber E, Khaw BA. 1991. Early detection of rejection and assessment of cyclosporine therapy by indium-111 antimyosin imaging in mouse heart allografts. Circulation 84:1246–1255.PubMedGoogle Scholar
  29. 29.
    Isobe M, Narula J, Strauss HW, Khaw BA, Haber E. 1992. Imaging the rejecting heart: in vivo detection of MHC class II antigen induction. Circulation 85:738–746.PubMedGoogle Scholar
  30. 30.
    Takei F. 1985. Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J Immunol 134:1403–1407.PubMedGoogle Scholar
  31. 31.
    Nishimura T, Yagi H, Yagita H, Uchiyama Y, Hashimoto Y. 1985. Lymphokine-activated cell-associated antigen involved in broadreactive killer cell-mediated cytotoxicity. Cell Immunol 94:122–132.PubMedCrossRefGoogle Scholar
  32. 32.
    Taylor PM, Rose ML, Yacoub MH, Pigott R. 1992. Induction of vascular adhesion molecules during rejection of human cardiac allografts. Transplantation 54:451–457.PubMedCrossRefGoogle Scholar
  33. 33.
    Isobe M, Suzuki J, Yagita H, Okumura K, Yamazaki S, Nagai R, Yazaki Y, Sekiguchi M. 1994. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-l and anti-very late antigen-4 monoclonal antibodies. J Immunol 153:5810–5818.PubMedGoogle Scholar
  34. 34.
    Ohtani H, Strauss HW, Southern JF, Miyasaka M, Tamatani T, Sekiguchi M, Isobe M. 1995. Intercellular adhesion molecule-1 induction: a sensitive and quantitative marker for cardiac allograft rejection. J Am Coll Cardiol 26:793–799.PubMedCrossRefGoogle Scholar
  35. 35.
    Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, Malden LT, Masuko H, Sato H. 1990. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 248:1009–1012.PubMedCrossRefGoogle Scholar
  36. 36.
    Nuovo GJ, Gallery F, MacConnell P, Braun A. 1994. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-a RNA in the central nervous system. Am J Pathol 144:659–666.PubMedGoogle Scholar
  37. 37.
    Horie S, Okubo Y, Suzuki J, Isobe M. 1996. An emaciated man with eosinophilic pneumonia. Lancet 348:166.PubMedCrossRefGoogle Scholar
  38. 38.
    Suzuki J, Isobe M, Ando A, Kasajima T, Sekiguchi M. 1997. In situ detection of cytokine mRNA in mice cardiac allograft rejection. Transplant Proc 29:1512.PubMedCrossRefGoogle Scholar
  39. 39.
    Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J 11:961–971.PubMedGoogle Scholar
  40. 40.
    Pagano M, Draetta G, Jansen DP. 1992. Association of cdk2 kinase with the transcription factor E2F during S phase. Science 255:1144–1147.PubMedCrossRefGoogle Scholar
  41. 41.
    Tsai LH, Harlow E, Meyerson M. 1991. Isolation of the human cdk2 gene that encodes the cyclin A-and adenovirus E1A-associated p33 kinase. Nature 353:174–177.PubMedCrossRefGoogle Scholar
  42. 42.
    Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J. 1993. Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science 260:536–539.PubMedCrossRefGoogle Scholar
  43. 43.
    Morishita R, Gibbons GH, Ellison KE, Nakajima M, von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. 1994. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest 93:1458–1464.PubMedCrossRefGoogle Scholar
  44. 44.
    Kaneda Y, Iwai K, Uchida T. 1989. Increased ecpression of DNA co-introduced with nuclear protein in adult rat liver. Science 243:375–378.PubMedCrossRefGoogle Scholar
  45. 45.
    Johnson MR. 1992. Transplant coronary disease: nonimunologic risk factors. J Heart Lung Transplant 11:S124–S132.PubMedGoogle Scholar
  46. 46.
    Grattan MT, Moreno CC, Starnes VA, Oyer PE, Stinson EB, Shumway NE. 1989. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561–3566.PubMedCrossRefGoogle Scholar
  47. 47.
    Loebe M, Schuler S, Zais O, Warnecke H, Fleck E, Hetzer R. 1990. Role of Cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant 9:707–711.PubMedGoogle Scholar
  48. 48.
    Salomon RN, Hughes CC, Schoen FJ, Payne DD, Pober JS, Libby P. 1991. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 138:791–798.PubMedGoogle Scholar
  49. 49.
    Page C, Rose M, Yacoub M, Pigott R. 1992. Antigenic heterogeneity of vascular endothelium. Am J Pathol 141:673–683.PubMedGoogle Scholar
  50. 50.
    Tanio JW, Basu CB, Albelda SM, Eisen HJ. 1994. Differential expression of the cell adhesion molecules ICAM-1, VCAM-1, and E-selectin in normal and posttransplantation myocardium. Cell adhesion molecule expression in human cardiac allografts. Circulation 89:1760–1768.PubMedGoogle Scholar
  51. 51.
    Jang Y, Lincoff AM, Plow EF, Topol EJ. 1994. Cell adhesion molecules in coronary artery disease. J Am Coll Cardiol 24:1591–1601.PubMedCrossRefGoogle Scholar
  52. 52.
    Koskinen PK, Lemstrom KB, Hayry PJ. 1995. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Am J Pathol 146:972–980.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Mitsuaki Isobe
    • 1
  • Jun-Ichi Suzuki
    • 1
  1. 1.Shinshu University School of MedicineJapan

Personalised recommendations